Caiwen Ou

3.6k total citations · 1 hit paper
107 papers, 2.9k citations indexed

About

Caiwen Ou is a scholar working on Molecular Biology, Biomaterials and Surgery. According to data from OpenAlex, Caiwen Ou has authored 107 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 29 papers in Biomaterials and 22 papers in Surgery. Recurrent topics in Caiwen Ou's work include Tissue Engineering and Regenerative Medicine (15 papers), Supramolecular Self-Assembly in Materials (13 papers) and Electrospun Nanofibers in Biomedical Applications (12 papers). Caiwen Ou is often cited by papers focused on Tissue Engineering and Regenerative Medicine (15 papers), Supramolecular Self-Assembly in Materials (13 papers) and Electrospun Nanofibers in Biomedical Applications (12 papers). Caiwen Ou collaborates with scholars based in China, United States and Macao. Caiwen Ou's co-authors include Minsheng Chen, Zhiye Wu, Jianyun Yan, Zhimou Yang, Hekai Li, Peier Chen, Xianglin Fan, Xiaodong Ning, Xinglong Zhong and Jianwu Zhang and has published in prestigious journals such as Advanced Materials, Nature Communications and ACS Nano.

In The Last Decade

Caiwen Ou

102 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals

2020 212 citations Pingzhen Yang, Caiwen Ou et al. profile →

Peers

Countries citing papers authored by Caiwen Ou

Since Specialization

Citations

This map shows the geographic impact of Caiwen Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caiwen Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caiwen Ou more than expected).

Fields of papers citing papers by Caiwen Ou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caiwen Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caiwen Ou. The network helps show where Caiwen Ou may publish in the future.

Co-authorship network of co-authors of Caiwen Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Caiwen Ou. A scholar is included among the top collaborators of Caiwen Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caiwen Ou. Caiwen Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Silicified curcumin microspheres Combats cardiovascular diseases via Nrf2/HO-1 pathway 2025 ·Bioactive Materials ·Tianwang Guan, (unknown), (unknown), (unknown), Zhaowenbin Zhang, Shaohui Deng, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Aihua Huang, Peier Chen, Chunming Wang, Caiwen Ou	2
2	AI-enabled molecular phenotyping and prognostic predictions in lung cancer through multimodal clinical information integration 2025 ·Cell Reports Medicine ·Yuxing Lu, (unknown), Yunfang Yu, Bojiang Chen, (unknown), (unknown), (unknown), (unknown), Caiwen Ou, Chengdi Wang, (unknown), Jinzhuo Wang, Xiaoying Huang	2
3	Association of genetically proxied cancer-targeted drugs with cardiovascular diseases through Mendelian randomization analysis 2025 ·Journal of Translational Medicine ·(unknown), Xue‐Wei Liu, Yu Chen, Songlin Li, Xueying Liu, (unknown), H. Liang, Caiwen Ou, (unknown)	1
4	NEXN protects against vascular calcification by promoting SERCA2 SUMOylation and stabilization 2025 ·Nature Communications ·Wenjie Guo, Wenjing Guo, (unknown), (unknown), Zhi‐Hong Wen, Jianping Ye, Wei Feng, Xin Feng, Jianyun Yan, Pingzhen Yang, Kunfu Ouyang, Yifei Li, (unknown), Caiwen Ou, Canzhao Liu	0
5	A nuclei bombing nano-system improves STING-activated cancer immunotherapy 2025 ·Nano Today ·Shuai Guo, Tianwang Guan, (unknown), Long Ma, (unknown), (unknown), (unknown), Yufei Pan, Ning Xu, (unknown), (unknown), Yafang Xiao, Shaohui Deng, Peier Chen, Zhenhua Li, Xiaozhong Qiu, Kelong Fan, Zheyu Shen, Caiwen Ou	2
6	Fluorinated BPA derivatives enhanced ¹⁰B delivery in tumors 2024 ·Journal of Materials Chemistry B ·Dandan Ding, (unknown), (unknown), (unknown), Xueyi Wang, Caiwen Ou, Zhenhua Li	3
7	A polyphenol-derived redox-active and conductive nanoparticle-reinforced hydrogel with wet adhesiveness for myocardial infarction repair by simultaneously stimulating anti-inflammation and calcium homeostasis pathways 2024 ·Nano Today ·Peier Chen, Wei Zhang, Xianglin Fan, (unknown), Yanan Jiang, Liwei Yan, Hekai Li, Chunming Wang, (unknown), Xiong Lu, Caiwen Ou	28
8	Oral probiotic extracellular vesicle therapy mitigates Influenza A Virus infection via blunting IL-17 signaling 2024 ·Bioactive Materials ·(unknown), (unknown), Jie‐Ting Li, Peier Chen, Lihan Shen, Wenjing Huang, (unknown), Hai Zou, (unknown), Yunceng Weng, Yuhua Liu, (unknown), Caiwen Ou	13
9	MRI‐Guided Tumor Therapy Based on Synergy of Ferroptosis, Immunosuppression Reversal and Disulfidptosis 2024 ·Small ·Shuai Guo, (unknown), (unknown), Jie Feng, Lin Huang, (unknown), Jiaoyang Zhu, (unknown), (unknown), (unknown), Qianqian Zhang, (unknown), Tianwang Guan, Peier Chen, (unknown), Chenggong Yan, Caiwen Ou, Zheyu Shen	25
10	An Integrated Arterial Remodeling Hydrogel for Preventing Restenosis After Angioplasty 2024 ·Advanced Science ·(unknown), Qiu Li, Minghui Li, (unknown), (unknown), (unknown), Dongyue He, (unknown), Xiaodong Ning, (unknown), (unknown), (unknown), (unknown), Guoqin Chen, (unknown), Caiwen Ou, Weisheng Guo	7
11	Monocyte Differentiation‐Surveilling Nano‐Shuttles for Activatable Targeted Inhibition of Atherosclerotic Plaque Progression 2023 ·Advanced Functional Materials ·(unknown), (unknown), Haoting Chen, Minghui Li, (unknown), Yuying Yao, (unknown), Xiaodong Ning, (unknown), Jun Zheng, (unknown), Guoqin Chen, Feng Cao, Caiwen Ou, Lu Liu, Weisheng Guo	9
12	Targeted heart repair by Tβ4-loaded cardiac-resident macrophage-derived extracellular vesicles modified with monocyte membranes 2023 ·Acta Biomaterialia ·Peier Chen, (unknown), Xiaodong Ning, (unknown), Jianfeng Zhong, Xianglin Fan, (unknown), (unknown), (unknown), Bin Yu, (unknown), Hekai Li, Caiwen Ou	28
13	Liposome-coated CaO2 nanoblockers for enhanced checkpoint blockade therapy by inhibiting PD-L1 de novo biosynthesis 2023 ·Nano Research ·(unknown), Dandan Han, Fei Wang, Huifang Liu, Miao Fan, Hongyu Yan, (unknown), (unknown), Xiaohan Zhou, Xueyi Wang, (unknown), Caiwen Ou, Jinchao Zhang, Zhenhua Li	2
14	Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer 2022 ·Cancers ·Tianwang Guan, Miao Su, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yanting Jiang, Caiwen Ou, Minsheng Chen	11
15	A dual-targeting peptide facilitates targeting anti-inflammation to attenuate atherosclerosis in ApoE^−/− mice 2022 ·Chemical Communications ·Bo Wu, (unknown), Jinmin Chen, Xianmei Pan, Xianglin Fan, Peier Chen, (unknown), Caiwen Ou, Minsheng Chen	7
16	Deficiency of proline/serine-rich coiled-coil protein 1 (PSRC1) accelerates trimethylamine N-oxide-induced atherosclerosis in ApoE−/− mice 2022 ·Journal of Molecular and Cellular Cardiology ·Tiantian Luo, Dan Liu, Zhongzhou Guo, Peier Chen, (unknown), (unknown), Caiwen Ou, Minsheng Chen	11
17	Osteomodulin is a Potential Genetic Target for Hypertrophic Cardiomyopathy 2021 ·Biochemical Genetics ·Wenjie Guo, Weijing Feng, Xianglin Fan, (unknown), Caiwen Ou, Minsheng Chen	8
18	Injectable AuNP-HA matrix with localized stiffness enhances the formation of gap junction in engrafted human induced pluripotent stem cell-derived cardiomyocytes and promotes cardiac repair 2021 ·Biomaterials ·Hekai Li, Bin Yu, Pingzhen Yang, Jie Zhan, Xianglin Fan, Peier Chen, Xu Liao, Caiwen Ou, Yanbin Cai, Minsheng Chen	48
19	Association Between Fasting Glucose Variability in Young Adulthood and the Progression of Coronary Artery Calcification in Middle Age 2020 ·Diabetes Care ·Weijing Feng, Zhibin Li, (unknown), Xianglin Fan, (unknown), Kun Zhang, Caiwen Ou, Feifei Huang, Minsheng Chen	14
20	YAP accelerates vascular senescence via blocking autophagic flux and activating mTOR 2020 ·Journal of Cellular and Molecular Medicine ·Xianmei Pan, Bo Wu, Xianglin Fan, Guanghui Xu, Caiwen Ou, Minsheng Chen	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact